We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

49 hedge funds and large institutions have $14.4M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more call options, than puts

Call options by funds: $31K | Put options by funds: $9K

16% less funds holding

Funds holding: 58 → 49 (-9)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

36% less capital invested

Capital invested by funds: $22.5M → $14.4M (-$8.04M)

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
49
Holders Change
-9
Holders Change %
-15.52%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
11
Reduced
14
Closed
11
Calls
$31K
Puts
$9K
Net Calls
+$22K
Net Calls Change
-$138K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$743K
2
SGAM
Smith Group Asset Management
Texas
+$201K
3
Deutsche Bank
Deutsche Bank
Germany
+$100K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$75.3K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$50.2K

Top Sellers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
-$1.28M
2
RCM
RA Capital Management
Massachusetts
-$320K
3
Two Sigma Investments
Two Sigma Investments
New York
-$56K
4
Morgan Stanley
Morgan Stanley
New York
-$48.2K
5
ARTA
A.R.T. Advisors
New York
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.24M +$743K +385 +15%
AI
2
Ariel Investments
Illinois
$3.42M -$13.5K -7 -0.3%
BIT
3
BlackRock Institutional Trust
California
$1.4M +$9.65K +5 +0.5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.11M +$50.2K +26 +4%
RCM
5
RA Capital Management
Massachusetts
$958K -$320K -166 -20%
Renaissance Technologies
6
Renaissance Technologies
New York
$538K +$13.5K +7 +2%
SGAM
7
Smith Group Asset Management
Texas
$438K +$201K +104 +53%
New York State Common Retirement Fund
8
New York State Common Retirement Fund
New York
$327K – – –
Jacobs Levy Equity Management
9
Jacobs Levy Equity Management
New Jersey
$272K +$75.3K +39 +26%
Deutsche Bank
10
Deutsche Bank
Germany
$207K +$100K +52 +57%
SAIG
11
Semper Augustus Investments Group
Colorado
$185K -$1.93K -1 -0.8%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$147K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$142K – – –
SIM
14
Spark Investment Management
New York
$98K -$3.86K -2 -3%
BCM
15
Bridgeway Capital Management
Texas
$92K – – –
Morgan Stanley
16
Morgan Stanley
New York
$88K -$48.2K -25 -29%
CCM
17
Condor Capital Management
New Jersey
$62K – – –
Northern Trust
18
Northern Trust
Illinois
$59K +$5.79K +3 +8%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$52K -$9.65K -5 -13%
Connor, Clark & Lunn Investment Management (CC&L)
20
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$50K +$11.6K +6 +21%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$49K +$3.86K +2 +6%
Goldman Sachs
22
Goldman Sachs
New York
$47K -$11.6K -6 -16%
BMM
23
Berkshire Money Management
Massachusetts
$40K – – –
HK
24
Horizon Kinetics
New York
$39K – – –
CCMH
25
Cornerstone Capital Management Holdings
New York
$33K – – –
1
2 3

FRTX Hedge Fund Activity: Q3 2015 in Review

49 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q3 2015, worth a combined $14.4M — down 36% from $22.5M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FRTX and 2 opened new positions — a net loss of 9 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was Fidelity Investments, adding an estimated $743K. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $1.28M sold.

  • 49 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q3 2015, down from 58 in Q2 2015.
  • Funds reported $14.4M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q3 2015, down 36% quarter-over-quarter.
  • 2 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q3 2015 and 11 closed out, a net change of -9 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q3 2015 was Fidelity Investments, an estimated $743K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q3 2015 was Rock Springs Capital Management, an estimated $1.28M sold.

Based on aggregated 13F filings for Q3 2015.